Maryland (MD) Asbestos Resources & Information:
The state of Maryland is fifth in terms of population density; currently this state, approximately the size of the E.U. country of Belgium, is home to 5.6 million. Between 1980 and 2000, the state's population increased by 25%. During that same period, asbestos disease accounted for over 1,000 deaths in that state. Roughly two people in 10,000 succumbed to asbestos disease, over half of whom were in the Baltimore area (city and county).
This figure is somewhat higher than the nation at large. It is also noteworthy that over 60% of these fatalities were due to asbestosis rather than mesothelioma. The latter is a rarer condition, and is invariably fatal; most patients diagnosed with mesothelioma die within 18 month of diagnosis.
Asbestosis, while far more common is also not usually immediately fatal if diagnosed before the disease has reached an advanced stage.
The difference may be due to a number of factors, including failure of the U.S. health care system; a large number of uninsured people without access to health care may go undiagnosed. Another reason may lie in the type of asbestos to which workers are exposed. Chrysotile, which is softer and curly, and amphibole, which is relatively hard and spear-shaped, are equally deadly. The difference between the two lies not in toxicity, but rather in degree; amphibole asbestos tends to act faster in causing the kind of cellular mutation that leads to the development of cancer.
Studies
Bethesda is home to the National Cancer Institute. A study by Institute doctors was recently carried out on 4,700 people who had worked at the Curtis Bay Coast Guard Shipyard between 1950 and 1963. The results proved what oncologists who see maritime industry employees have long suspected: shipyard workers run a significantly higher risk of contracting asbestos disease than the population at large. The same risks are faced by those employed at civilian shipyards as well, such as Bethlehem Shipbuilding.
The same is true of those who worked at one of Maryland's power generating facilities. Results of a study by doctors in Puerto Rico, presented in November of 2007, showed that 13% of all chest x-rays taken of power plant workers displayed some type of anomaly. Power plants in Maryland that have been identified as having asbestos problems include the Basco Power Electric, the Calvert Cliffs Nuclear Power Plant and the Glen Burnie Powerhouse.
All powerhouses have made use of asbestos-containing materials (ACMs) at some point in their history because its usefulness as an electrical insulator. Conduit lagging, electrical cloth tape and even components of turbines and generators are all places where asbestos (particularly of the amphibole type) has been used.
The White House Connection
It is common knowledge that Vice President Richard "Dick" Cheney was formerly CEO of Halliburton, that he received substantial amounts of "deferred compensation" from Halliburton even while serving as Vice President, and that this company has made very large profits from non-bid contracts granted in connection with the war in Iraq.
It is less known that this corporation has a large number of asbestos lawsuits pending against it. Halliburton's primary interest is petroleum, which is an industry notorious for asbestos exposure. This company has been named in lawsuits filed in the state of Maryland; while this does not mean that Halliburton itself has facilities in the state, it is a large corporation with numerous subsidiaries in virtually every state. According to a company profile:
Halliburton and its subsidiaries had for years manufactured construction products that contained asbestos... in 2003, Halliburton had a net income loss of $820 million because of bankruptcies related to its exposure to asbestos liability. A settlement of Halliburton's asbestos lawsuits was executed in 2004 and the company subsequently became profitable again.
Buildings
Supradur Manufacturing was a company that made products from asbestos cement--a substance consisting of Portland cement and various types of asbestos fibers (primarily chrysotile). It is likely that some of these products found their way into the construction of the University of Maryland Stadium, which has been yet another problem location.
Locations
Asbestos fatalities were substantially lower in Maryland's rural areas, but still higher than comparable parts of the nation. The lowest rates of asbestos disease were in Garrett, Kent and Saint Mary's counties, in which there were only three asbestos-related deaths during the 20-year period prior to 2000.
Maryland (MD) Asbestos & Mesothelioma Doctors
The diagnosis and treatment of asbestos-related cancers and other diseases is gradually becoming a sub-specialty in the field of medicine all its own. However, as of the present time, there is no medical degree that is specific to asbestos-related practice.
Most doctors focusing on asbestos disease today are trained in oncology, thoracic surgery, respiratory or occupational medicine, or some related field. Below is a list of doctors in Maryland (MD) that specialize in some form of asbestos cancer or mesothelioma treatment and the institution they are currently affiliated with:
Dr. Mark J. Krasna (Click on name for more info...)
Medical Director at Cancer Institute at St. Joseph Medical Center
Towson, Maryland (MD)
Dr. Stephen C. Yang (Click on name for more info...)
Associate Professor of Surgery and Oncology at Johns Hopkins University School of Medicine, Division of Thoracic Surgery
Baltimore, Maryland (MD)
Maryland (MD) Asbestos & Mesothelioma Treatment Centers
Today, between 25 and 30% of all Americans will get some form of cancer during their lifetimes. There are many reasons for this, including the modern lifestyle and the poisons that have been put into the environment – of which asbestos is a prime example.
The number of clinics and hospitals that specialize in oncology have increased in response to the growing number of patients. Below is a list of the cancer treatment centers located in Maryland (MD) that we feature on Asbestos.net:
National Cancer Institute
Bethesda, Maryland (MD)
University of Maryland Marlene and Stewart
Baltimore, Maryland (MD)
University of Maryland Medical Center, Division of Thoracic Surgery
Baltimore, Maryland (MD)
University of Maryland School of Medicine,
Baltimore, Maryland (MD)
Clinical Trials Serving Maryland (MD):
A clinical trial is when new medications and treatments are tested on human subjects. Participation in such studies can entail some risks, but for some who are facing an invariably fatal disease, they also represent an opportunity – not only for personal relief, but to serve the greater good in the advancement of medical knowledge.
Below is a list of clinical trials with locations in Maryland (MD):
Identifier: NCT00025207 (Click for more info...)
Title: A Phase II Study Of ZD 1839 (NSC 715055, IND 61187) In Patients With Malignant Mesothelioma
Information Profided By: National Cancer Institute (NCI)
Trial Status: Completed
Identifier: NCT00509041 (Click for more info...)
Title: A Phase II Study of Dasatinib (NSC #732517) in Patients With Previously Treated Malignant Mesothelioma
Information Profided By: National Cancer Institute (NCI)
Trial Status: Recruiting
Identifier: NCT00003034 (Click for more info...)
Title: ONCONASE Plus Doxorubicin Versus Doxorubicin For Patients With Malignant Pleural or Peritoneal Mesothelioma Who Have Had No More Than One Prior Chemotherapy Regimen
Information Profided By: National Cancer Institute (NCI)
Trial Status: Active, Not Recruiting
Identifier: NCT00575770 (Click for more info...)
Title: A Phase I, Single Center, Dose-Escalation Study of CAT-5001 Administered Concurrently With Pemetrexed and Cisplatin in Subjects With Unresectable Malignant Epithelial Pleural Mesothelioma
Information Profided By: National Cancer Institute (NCI)
Trial Status: Recruiting
Identifier: NCT00101283 (Click for more info...)
Title: Pemetrexed Plus Gemcitabine Or Carboplatin In Patients With Advanced Malignant Mesothelioma: A Randomized Phase II Trial
Information Profided By: National Cancer Institute (NCI)
Trial Status: Recruiting
Identifier: NCT00107432 (Click for more info...)
Title: A Phase II Study of BAY 43-9006 (NSC #724772, IND #69896) in Patients With Malignant Mesothelioma
Information Profided By: National Cancer Institute (NCI)
Trial Status: Active, Not Recruiting
Identifier: NCT00004183 (Click for more info...)
Title: Capecitabine (Xeloda) in Malignant Mesothelioma: A Phase II Study
Information Profided By: National Cancer Institute (NCI)
Trial Status: Active, Not Recruiting
Identifier: NCT00053885 (Click for more info...)
Title: A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Information Profided By: National Cancer Institute (NCI)
Trial Status: Active, Not Recruiting
Identifier: NCT00447447 (Click for more info...)
Title: Prospective Evaluation of Epigenetic Alterations in Patients With Lung and Esophageal Cancers and Malignant Pleural Mesotheliomas
Information Profided By: National Cancer Institute (NCI)
Trial Status: Recruiting
Identifier: NCT00027703 (Click for more info...)
Title: A Double Blind, Placebo Controlled Randomized Phase II Trial Of Gemcitabine And Cisplatin With Or Without The VEGF Inhibitor Bevacizumab (NSC #704865) In Patients With Malignant Mesotheloma
Information Profided By: National Cancer Institute (NCI)
Trial Status: Completed
Identifier: NCT00019825 (Click for more info...)
Title: Phase I Study of Decitabine Mediated Induction of Tumor Antigen and Tumor Suppressor Gene Expression in Lung Cancer Patients
Information Profided By: National Cancer Institute (NCI)
Trial Status: Completed
Identifier: NCT00041158 (Click for more info...)
Title: Phase I Study of Gene Induction Mediated by Sequential Decitabine/Depsipeptide Infusion in Subjects With Pulmonary and Pleural Malignancies
Information Profided By: National Cancer Institute (NCI)
Trial Status: Recruiting
Identifier: NCT00272558 (Click for more info...)
Title: Phase II Study of Carboplatin and Vinorelbine i.v. (Day 1) and Orally (Day 8) for Malignant Pleural Mesothelioma.
Information Profided By: Rigshospitalet, Denmark
Trial Status: Recruiting
Identifier: NCT00325494 (Click for more info...)
Title: A Study of the Safety, Tolerability, and Pharmacokinetics of MORAb-009, a Chimeric Monoclonal Antibody, in Subjects With Advanced Mesothelin-Expressing Tumors
Information Profided By: Morphotek
Trial Status: Active, Not Recruiting
Identifier: NCT00571298 (Click for more info...)
Title: A Phase I Trial of Extrapleural Pneumonectomy, Intrathoracic/Intraperitoneal Hyperthermic (IOHC) Cisplatin and Gemcitabine With Intravenous Amifostine and Sodium Thiosulfate Cytoprotection for Patients With Resectable Malignant Pleural Mesothelioma
Information Profided By: Dana-Farber Cancer Institute
Trial Status: Recruiting
Identifier: NCT00066651 (Click for more info...)
Title: Phase I Study Of SS1(dsFv)-PE38 Anti-Mesothelin Immunotoxin In Advanced Malignancies: I.V. Infusion QOD Dosing
Information Profided By: National Cancer Institute (NCI)
Trial Status: Completed
Identifier: NCT00020124 (Click for more info...)
Title: Phase I and Clinical Pharmacologic Study of Inhaled Doxorubicin in Adults With Advanced Solid Tumors Affecting the Lungs
Information Profided By: National Cancer Institute (NCI)
Trial Status: Completed
Identifier: NCT00098644 (Click for more info...)
Title: Phase I Study Of Sequential Depsipeptide/Flavopiridol Infusion for Malignancies Involving Lungs, Esophagus, Pleura or Mediastinum
Information Profided By: National Cancer Institute (NCI)
Trial Status: Recruiting
Identifier: NCT00006981 (Click for more info...)
Title: Phase I Study Of SS1(dsFv)-PE38 (SS1P) Anti-Mesothelin Immunotoxin in Advanced Malignancies: Continuous Infusion X 10 Days
Information Profided By: National Cancer Institute (NCI)
Trial Status: Completed
Identifier: NCT00585845 (Click for more info...)
Title: A Phase 1, Open-Label, Dose-Escalation, Multiple Dose Study of the Safety, Tolerability, and Immune Response of CRS-207 in Adult Subjects With Selected Advanced Solid Tumors Who Have Failed or Who Are Not Candidates for Standard Treatment
Information Profided By: Anza Therapeutics, Inc.
Trial Status: Recruiting
Identifier: NCT00087698 (Click for more info...)
Title: A Multicenter Phase II Trial of Neo-Adjuvant Pemetrexed (Alimta) Plus Cisplatin Followed by Surgery and Radiation for Pleural Mesothelioma
Information Profided By: Eli Lilly and Company
Trial Status: Active, Not Recruiting
Identifier: NCT00020579 (Click for more info...)
Title: A Phase I Study of an Oral Histone Deacetylase Inhibitor, MS-275, in Refractory Solid Tumors and Lymphomas
Information Profided By: National Cancer Institute (NCI)
Trial Status: Active, Not Recruiting
Identifier: NCT00024674 (Click for more info...)
Title: Study of SS1(dsFv)-PE38 (SS1P) Anti-Mesothelin Immunotoxin in Advanced Malignancies: Continuous Infusion for 10 Days
Information Profided By: Neopharm
Trial Status: Terminated
Identifier: NCT00024687 (Click for more info...)
Title: Study of SS1(dsFv)-PE38 (SS1P) Anti-Mesothelin Immunotoxin in Advanced Malignancies: IV Infusion QOD x Six Doses
Information Profided By: Neopharm
Trial Status: Terminated
Maryland (MD) Legal Resources: Asbestos, Asbestos Cancer & Mesothelioma
A search through the Maryland Federal District Court Cases for asbestos-related personal injury lawsuits brings up a list of one dozen recent lawsuits from 2006 and 2007. It should be noted that about half of these lawsuits were not individuals suing corporations or companies but rather companies' petitions for removal from asbestos litigation.
Maryland is ranked 16 in the U.S. for mesothelioma cases. With a mesothelioma mortality rate of 12.52 per million, Maryland has a crude mortality rank of 24 in the country. Among the sites that have been identified as having a high asbestos exposure risk are: Nuclear Power School in Bainbridge; Curtis Bay Coast Guard in Baltimore; Basco Power Electric in Basco; the University of Maryland Stadium in College Park; Glen Burnie Powerhouse in Glen Burnie; Luke Paper Company in Luke; Calvert Cliffs Nuclear Power Plant in Lusby; and Bethlehem Shipbuilding in Sparrows Point. Anyone who has spent time in these areas will want to be checked by a physician and will want to keep track of any unusual symptoms. It is important to keep in mind, however, that these may not be the only sites in the state which may have exposed workers and visitors to asbestos.
In Maryland, lawsuits arising from asbestos exposure are far from rare. In July 2007, three families were awarded $3.97 million in what attorneys predict will be the first of hundreds of like cases. The families of three former Bethlehem Steel workers sued General Electric in Baltimore Circuit Court because the mills used asbestos-lined industrial brakes in equipment. The three men named in the lawsuit passed away from lung cancer before the case was brought before the courts.
Another key asbestos case in the state occurred in 1999, when the U.S. settled a suit against Maryland's Department of General Services. The lawsuit arose over allegations that the department violated federal asbestos regulations when the Clifton T. Perkins Hospital in Jessup, Maryland, was renovated in 1993. After the decision, the state not only had to pay a penalty, but also had to promise to prevent future asbestos violations in public buildings. The state also agreed to make at least one visual inspection of all asbestos removal projects conducted in public buildings and agreed to conduct background checks any on asbestos contractors hired to work on public buildings. The contractor that the state hired for the 1993 renovation, Manassas-based Absolute Enterprises, was found to have violated a number of regulations concerning the handling of asbestos. As a result of the lawsuit, the state promised to alert the Maryland Department of the Environment of any problems regarding asbestos violations. The state further stated that they would have a trained asbestos program manager oversee compliance at asbestos projects in state buildings.
Those interested in filing lawsuits should know that the statute of limitations for personal injury law in Maryland is three years with a discovery rule which states that the statute of limitations begins to run when the plaintiff discovers or should have discovered the injury (in this case, mesothelioma). The plaintiff must have knowledge, either implied or express, of the injury in order to trigger the running of the statute of limitations.
There is no specific statute about asbestos. However, there is a specific ruling related to wrongful death suits. The statute of limitations on all personal injury wrongful death suits is three years from date of death unless caused by occupational disease, in which case the statute of limitations is the shorter of 10 years from death or three years from time the cause of death is discovered. A Maryland appellate court ruled that a widow's wrongful death action was timely if she was unaware that asbestos exposure was the cause of her late husband's mesothelioma.
Loading Video...
This article is part of the Asbestos.net 'Watch This Article' Series: A collection of our in-depth and informative articles that have been recorded as high quality videos to allow for ease of access by all of our visitors.